APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

D(-) Alpha Parahydroxy Phenylglycine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global D(-) Alpha Parahydroxy Phenylglycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173982210323 December 2025186 pages

Choose your research edition.

Industry ResearchD(-) Alpha Parahydroxy Phenylglycine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal D(-) Alpha Parahydroxy Phenylglycine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal D(-) Alpha Parahydroxy Phenylglycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal D(-) Alpha Parahydroxy Phenylglycine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal D(-) Alpha Parahydroxy Phenylglycine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global D(-) Alpha Parahydroxy Phenylglycine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for D(-) Alpha Parahydroxy Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for D(-) Alpha Parahydroxy Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for D(-) Alpha Parahydroxy Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for D(-) Alpha Parahydroxy Phenylglycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of D(-) Alpha Parahydroxy Phenylglycine include Zhejiang Yuntao Biotechnology, Henan Newland Pharmaceutical, Shanghai Banglin Biotechnology, Apeloa Pharmaceutical, Deretil and Daurala Organics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global D(-) Alpha Parahydroxy Phenylglycine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of D(-) Alpha Parahydroxy Phenylglycine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents D(-) Alpha Parahydroxy Phenylglycine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the D(-) Alpha Parahydroxy Phenylglycine market size, projected growth trends, production technologies, key applications, and end-use industries.

D(-) Alpha Parahydroxy Phenylglycine Segment by Company

Zhejiang Yuntao Biotechnology

Henan Newland Pharmaceutical

Shanghai Banglin Biotechnology

Apeloa Pharmaceutical

Deretil

Daurala Organics

D(-) Alpha Parahydroxy Phenylglycine Segment by Type

Content 98%

Content 98.5%

D(-) Alpha Parahydroxy Phenylglycine Segment by Application

Amoxicillin

Cephalosporins

D(-) Alpha Parahydroxy Phenylglycine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global D(-) Alpha Parahydroxy Phenylglycine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of D(-) Alpha Parahydroxy Phenylglycine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of D(-) Alpha Parahydroxy Phenylglycine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the D(-) Alpha Parahydroxy Phenylglycine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of D(-) Alpha Parahydroxy Phenylglycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of D(-) Alpha Parahydroxy Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of D(-) Alpha Parahydroxy Phenylglycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. D(-) Alpha Parahydroxy Phenylglycine Industry Trends Table 2. D(-) Alpha Parahydroxy Phenylglycine Industry Drivers Table 3. D(-) Alpha Parahydroxy Phenylglycine Industry Opportunities and Challenges Table 4. D(-) Alpha Parahydroxy Phenylglycine Industry Restraints Table 5. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Manufacturers Table 9. Global D(-) Alpha Parahydroxy Phenylglycine Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global D(-) Alpha Parahydroxy Phenylglycine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global D(-) Alpha Parahydroxy Phenylglycine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global D(-) Alpha Parahydroxy Phenylglycine Manufacturers, Product Type & Application Table 13. Global D(-) Alpha Parahydroxy Phenylglycine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global D(-) Alpha Parahydroxy Phenylglycine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Content 98% Table 17. Major Manufacturers of Content 98.5% Table 18. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type (2021-2026) & (k units) Table 20. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type (2027-2032) & (k units) Table 21. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Type (2021-2026) Table 22. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Type (2027-2032) Table 23. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type (2021-2026) & (k units) Table 25. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type (2027-2032) & (k units) Table 26. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Type (2021-2026) Table 27. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Amoxicillin Table 29. Major Manufacturers of Cephalosporins Table 30. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application (2021-2026) & (k units) Table 32. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application (2027-2032) & (k units) Table 33. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Application (2021-2026) Table 34. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Application (2027-2032) Table 35. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application (2021-2026) & (k units) Table 37. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application (2027-2032) & (k units) Table 38. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Application (2021-2026) Table 39. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Application (2027-2032) Table 40. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region (2021-2026) & (k units) Table 42. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Region (2021-2026) Table 43. Global D(-) Alpha Parahydroxy Phenylglycine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global D(-) Alpha Parahydroxy Phenylglycine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2026) & (k units) Table 47. North America D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2027-2032) & (k units) Table 48. Europe D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2026) & (k units) Table 50. Europe D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2027-2032) & (k units) Table 57. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Region (2021-2026) Table 61. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Yuntao Biotechnology Company Information Table 63. Zhejiang Yuntao Biotechnology Business Overview Table 64. Zhejiang Yuntao Biotechnology D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Yuntao Biotechnology D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 66. Zhejiang Yuntao Biotechnology Recent Development Table 67. Henan Newland Pharmaceutical Company Information Table 68. Henan Newland Pharmaceutical Business Overview Table 69. Henan Newland Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Henan Newland Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 71. Henan Newland Pharmaceutical Recent Development Table 72. Shanghai Banglin Biotechnology Company Information Table 73. Shanghai Banglin Biotechnology Business Overview Table 74. Shanghai Banglin Biotechnology D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shanghai Banglin Biotechnology D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 76. Shanghai Banglin Biotechnology Recent Development Table 77. Apeloa Pharmaceutical Company Information Table 78. Apeloa Pharmaceutical Business Overview Table 79. Apeloa Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Apeloa Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 81. Apeloa Pharmaceutical Recent Development Table 82. Deretil Company Information Table 83. Deretil Business Overview Table 84. Deretil D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Deretil D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 86. Deretil Recent Development Table 87. Daurala Organics Company Information Table 88. Daurala Organics Business Overview Table 89. Daurala Organics D(-) Alpha Parahydroxy Phenylglycine Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Daurala Organics D(-) Alpha Parahydroxy Phenylglycine Product Portfolio Table 91. Daurala Organics Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. D(-) Alpha Parahydroxy Phenylglycine Distributors List Table 95. D(-) Alpha Parahydroxy Phenylglycine Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. D(-) Alpha Parahydroxy Phenylglycine Product Image Figure 2. Global D(-) Alpha Parahydroxy Phenylglycine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global D(-) Alpha Parahydroxy Phenylglycine Market Size (2021-2032) & (US$ Million) Figure 4. Global D(-) Alpha Parahydroxy Phenylglycine Sales (2021-2032) & (k units) Figure 5. Global D(-) Alpha Parahydroxy Phenylglycine Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 D(-) Alpha Parahydroxy Phenylglycine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Content 98% Image Figure 9. Content 98.5% Image Figure 10. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Type (2021-2032) Figure 13. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Type (2021-2032) Figure 16. Amoxicillin Image Figure 17. Cephalosporins Image Figure 18. Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Application (2021-2032) Figure 21. Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Application (2021-2032) Figure 24. North America D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Country (2021-2032) Figure 26. U.S. D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Country (2021-2032) Figure 31. Germany D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Country (2021-2032) Figure 38. China D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Country (2021-2032) Figure 46. Brazil D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile D(-) Alpha Parahydroxy Phenylglycine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global D(-) Alpha Parahydroxy Phenylglycine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032) & (US$ Million) Figure 57. North America D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032) & (US$ Million) Figure 59. Europe D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. D(-) Alpha Parahydroxy Phenylglycine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. D(-) Alpha Parahydroxy Phenylglycine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Content 98%
  • Content 98.5%
Applications
  • Amoxicillin
  • Cephalosporins
Companies covered
  • Zhejiang Yuntao Biotechnology
  • Henan Newland Pharmaceutical
  • Shanghai Banglin Biotechnology
  • Apeloa Pharmaceutical
  • Deretil
  • Daurala Organics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global D(-) Alpha Parahydroxy Phenylglycine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global D(-) Alpha Parahydroxy Phenylglycine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global D(-) Alpha Parahydroxy Phenylglycine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global D(-) Alpha Parahydroxy Phenylglycine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global D(-) Alpha Parahydroxy Phenylglycine Market Dynamics
  1. 2.1 D(-) Alpha Parahydroxy Phenylglycine Industry Trends
  2. 2.2 D(-) Alpha Parahydroxy Phenylglycine Industry Drivers
  3. 2.3 D(-) Alpha Parahydroxy Phenylglycine Industry Opportunities and Challenges
  4. 2.4 D(-) Alpha Parahydroxy Phenylglycine Industry Restraints
3 D(-) Alpha Parahydroxy Phenylglycine Market by Manufacturers
  1. 3.1 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Manufacturers (2021-2026)
  3. 3.3 Global D(-) Alpha Parahydroxy Phenylglycine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global D(-) Alpha Parahydroxy Phenylglycine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global D(-) Alpha Parahydroxy Phenylglycine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global D(-) Alpha Parahydroxy Phenylglycine Manufacturers, Product Type & Application
  7. 3.7 Global D(-) Alpha Parahydroxy Phenylglycine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global D(-) Alpha Parahydroxy Phenylglycine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 D(-) Alpha Parahydroxy Phenylglycine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 D(-) Alpha Parahydroxy Phenylglycine Tier 1, Tier 2, and Tier 3
4 D(-) Alpha Parahydroxy Phenylglycine Market by Type
  1. 4.1 D(-) Alpha Parahydroxy Phenylglycine Type Introduction
  2. 4.1.1 Content 98%
  3. 4.1.2 Content 98.5%
  4. 4.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type
  5. 4.2.1 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Type (2021-2032)
  7. 4.2.3 Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Type (2021-2032)
  8. 4.3 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type
  9. 4.3.1 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Type (2021-2032)
  11. 4.3.3 Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Type (2021-2032)
5 D(-) Alpha Parahydroxy Phenylglycine Market by Application
  1. 5.1 D(-) Alpha Parahydroxy Phenylglycine Application Introduction
  2. 5.1.1 Amoxicillin
  3. 5.1.2 Cephalosporins
  4. 5.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application
  5. 5.2.1 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Application (2021-2032)
  7. 5.2.3 Global D(-) Alpha Parahydroxy Phenylglycine Sales Market Share by Application (2021-2032)
  8. 5.3 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application
  9. 5.3.1 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Application (2021-2032)
  11. 5.3.3 Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Application (2021-2032)
6 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region
  1. 6.1 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region (2021-2032)
  3. 6.2.1 Global D(-) Alpha Parahydroxy Phenylglycine Sales by Region (2021-2026)
  4. 6.2.2 Global D(-) Alpha Parahydroxy Phenylglycine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region
  1. 7.1 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region
  2. 7.1.1 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region (2021-2026)
  4. 7.1.3 Global D(-) Alpha Parahydroxy Phenylglycine Revenue by Region (2027-2032)
  5. 7.1.4 Global D(-) Alpha Parahydroxy Phenylglycine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032)
  8. 7.2.2 North America D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032)
  11. 7.3.2 Europe D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa D(-) Alpha Parahydroxy Phenylglycine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Yuntao Biotechnology
  2. 8.1.1 Zhejiang Yuntao Biotechnology Company Information
  3. 8.1.2 Zhejiang Yuntao Biotechnology Business Overview
  4. 8.1.3 Zhejiang Yuntao Biotechnology D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Yuntao Biotechnology D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  6. 8.1.5 Zhejiang Yuntao Biotechnology Recent Developments
  7. 8.2 Henan Newland Pharmaceutical
  8. 8.2.1 Henan Newland Pharmaceutical Company Information
  9. 8.2.2 Henan Newland Pharmaceutical Business Overview
  10. 8.2.3 Henan Newland Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Henan Newland Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  12. 8.2.5 Henan Newland Pharmaceutical Recent Developments
  13. 8.3 Shanghai Banglin Biotechnology
  14. 8.3.1 Shanghai Banglin Biotechnology Company Information
  15. 8.3.2 Shanghai Banglin Biotechnology Business Overview
  16. 8.3.3 Shanghai Banglin Biotechnology D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Banglin Biotechnology D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  18. 8.3.5 Shanghai Banglin Biotechnology Recent Developments
  19. 8.4 Apeloa Pharmaceutical
  20. 8.4.1 Apeloa Pharmaceutical Company Information
  21. 8.4.2 Apeloa Pharmaceutical Business Overview
  22. 8.4.3 Apeloa Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apeloa Pharmaceutical D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  24. 8.4.5 Apeloa Pharmaceutical Recent Developments
  25. 8.5 Deretil
  26. 8.5.1 Deretil Company Information
  27. 8.5.2 Deretil Business Overview
  28. 8.5.3 Deretil D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Deretil D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  30. 8.5.5 Deretil Recent Developments
  31. 8.6 Daurala Organics
  32. 8.6.1 Daurala Organics Company Information
  33. 8.6.2 Daurala Organics Business Overview
  34. 8.6.3 Daurala Organics D(-) Alpha Parahydroxy Phenylglycine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Daurala Organics D(-) Alpha Parahydroxy Phenylglycine Product Portfolio
  36. 8.6.5 Daurala Organics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 D(-) Alpha Parahydroxy Phenylglycine Value Chain Analysis
  2. 9.1.1 D(-) Alpha Parahydroxy Phenylglycine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 D(-) Alpha Parahydroxy Phenylglycine Production Mode & Process
  6. 9.2 D(-) Alpha Parahydroxy Phenylglycine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 D(-) Alpha Parahydroxy Phenylglycine Distributors
  9. 9.2.3 D(-) Alpha Parahydroxy Phenylglycine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst